Innovating at the Intersection: AI, Healthcare, and Venture Capital with Doug Nissinoff, Managing Director and Founder at Intelligence Ventures, EN #17

In this week’s podcast episode, we are excited to welcome Doug
Nissinoff, Managing Director and Founder at Intelligence Ventures
as well as Principal and Founder at Renegade BioConsulting.


Intelligence Ventures emerged as a pioneering venture capital
firm, dedicated to propelling innovation at the nexus of
artificial intelligence and healthcare within the United States.
Their focal point lies in strategically investing and nurturing
pre-seed, seed, and Series A companies, fostering their growth
and shaping the future of the industry.


Renegade BioConsulting, a global executive consultancy,
specialises in international expansion, corporate communications,
fundraising, and commercialization for companies within the
Biotech, Pharma, and MedTech sectors.


In this episode, we delve into the dynamic world of healthcare
and artificial intelligence. Tune in as our guest shares their
remarkable career journey and insights at the intersection of
these two transformative fields. Get ready for an in-depth
analysis of the current landscape of venture capital and
activities within the healthcare and AI industries. Discover the
profound significance of AI in revolutionising the healthcare
sector and unravel the investment strategies meticulously crafted
by Intelligent Ventures. Gain valuable insights into the
distinctions between the US and European investment markets, and
explore the pivotal role played by VC firms in driving
innovation. Learn about the crucial aspect of secondary
investments and their impact on the industry.


Don’t miss out on this enlightening discussion packed with
valuable perspectives and actionable takeaways!